#fasttrackdesignation
LightNews LightNews
kenaitx.bsky.social
We dosed the first patient in our Phase 1 REPLACE trial evaluating RNDP-001, a neuron replacement cell therapy for idiopathic #ParkinsonsDisease. RNDP-001 also received #FDA #FastTrackDesignation. Learn more: bit.ly/4qdLUe0
December 15, 2025 at 1:04 PM
oncodaily.bsky.social
Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia

oncodaily.com/drugs/nurix-...

#Cancer #EMA #PRIMEDesignation #FDA #Medicine #FastTrackDesignation #NurixTherapeutics #OncoDaily #Oncology #Health
Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia - OncoDaily
Nurix Therapeutics has Received FDA’s Fast Track Designation for NX-5948 in Waldenstrom’s Macroglobulinemia / Arthur T. Sands, cancer, EMA PRIME Designation,
oncodaily.com
December 24, 2024 at 5:36 PM
kstrategyand.bsky.social
www.linkedin.com/pulse/breakt...

Breakthrough for Lantern: LP-184 Gains Fast Track Designation for Aggressive Breast Cancer

kstrategyand.com/pharma-news

#CancerResearch #FDA #TNBC #FastTrackDesignation #Oncology #NewTherapies #ClinicalTrials #Humanteconomy #Humantech #KStrategyand
Breakthrough for Lantern: LP-184 Gains Fast Track Designation for Aggressive Breast Cancer
Lantern Pharma Inc., a pioneering artificial intelligence (AI)-driven biopharmaceutical company focused on revolutionizing cancer drug discovery, has announced that its investigational drug candidate,...
www.linkedin.com
January 10, 2025 at 10:39 AM
4040rec.bsky.social
#drugdevelopment #Clinicaltrials #RandD #clinicalresearch #neurodegeneration #regenerativemedicine #clinicaltrialdevelopments #orphandrugdesignation #preclinicaldata #fasttrackdesignation #expandedaccess #FDApriorityreview #clinicalprogress #strategicfunding
zurl.co/jmZiW
Q3 Clinical trials round-up: July to September 2025
As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.
zurl.co
October 15, 2025 at 11:15 AM
4040rec.bsky.social
#EVERSANA #OSTherapies #IterumTherapeutics #OSTHER2 #paediatricosteosarcoma #immunotherapy #OrphanDesignation #FastTrackDesignation #RarePediatricDiseaseDesignation #BLAsubmission #EVERSANAONCOLOGY #ORLYNVAH #ProductCommercializationAgreement #oralpenemantibiotic
pharmaphorum.com/market-acces...
EVERSANA expands commercialisation portfolio with OS Therapies and Iterum Therapeutics partnerships
pharmaphorum.com
July 1, 2025 at 9:19 AM
4040rec.bsky.social
#pharmaceuticals #Rheumatology #NeuromuscularDisease #Argenx #efgartigimod #efgartigimoddata #EULAR2025 #Sjogrensdisease #myositis #FastTrackdesignation #primarySjogrensdisease #ALKIVIAstudy #myositispatients #FcRninhibitor #UNITYtrial
pharmatimes.com/news/argenx-...
Argenx presents new efgartigimod data at EULAR 2025 - PharmaTimes
Rheumatology studies show promising results for Sjogren’s disease
pharmatimes.com
June 17, 2025 at 9:34 AM
pharmaphorum.bsky.social
One of the pioneers of in vivo #celltherapy, #UmojaBiopharma, has cleared another regulatory milestone after getting a #fasttrackdesignation from the FDA for its lead candidate for #bloodcancers, partnered with #AbbVie.
Umoja's in vivo cell therapy fast-tracked by FDA
A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.
buff.ly
October 1, 2025 at 1:30 PM
kstrategyand.bsky.social
www.linkedin.com/pulse/corbus...

Corbus Pharmaceuticals' CRB-701 Gains Fast Track Designation for Metastatic Cervical Cancer

kstrategyand.com/pharma-news

#CRB701 #FastTrackDesignation #CervicalCancer #Oncology #FDAApproval #CancerCare #Humanteconomy #Humantech #KStrategyand
Corbus Pharmaceuticals' CRB-701 Gains Fast Track Designation for Metastatic Cervical Cancer
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has announced that its investigational drug CRB-701 has received Fast Track designation from the U.
www.linkedin.com
January 13, 2025 at 9:42 AM